Most newly diagnosed patients with epilepsy do gain lasting control of their seizures, even if their first medication doesn’t ...
Medication has long been the cornerstone of treatment for people with epilepsy, but it doesn't stop seizures for everyone and ...
Our Lady of the Lake Children's Hospital opened a epilepsy monitoring unit on July 4, 2025, the first ever unit in the Baton ...
Axsome Therapeutics has wrapped its hands around an epilepsy candidate from AstraZeneca through an acquisition of Avenue ...
Dreamstime/TNS PHOENIX — Medication has long been the cornerstone of treatment for people with epilepsy, but it doesn’t stop ...
Doctors and researchers at the University of Pittsburgh and UPMC have developed a new treatment for epilepsy patients who don't respond to medication and aren't candidates for surgery. Their approach, ...
Hosted on MSN
New drug approval innovation process No. 1 new drug is XCOPRIZE, a treatment for adult epilepsy pati...
The treatment for adult epilepsy patients 'Excoprijeong (Senovamate)' has been approved as the 41st new drug developed in Korea. The Ministry of Food and Drug Safety said the drug is authorized as an ...
For the millions of people worldwide living with severe forms of epilepsy, some do not respond to medication and it can be ...
Patients with treatment-resistant epilepsy often cycle through multiple medications as they seek relief from the seizures ...
Biopharma company Jazz Pharmaceuticals (NASDAQ:JAZZ) reported Q3 CY2025 results exceeding the market’s revenue expectations, ...
University of British Columbia researchers say a new epilepsy drug holds promise as a treatment for Alzheimer's disease. The findings, published today in Alzheimer's Research & Therapy, reinforce the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results